Versant Ventures related stories
All articles and analysis
Health Care Status UpdateAt the JP Morgan Healthcare Conference in San Francisco, investors and entrepreneurs discuss what's hot and what will produce the best exit
Sorin Group Invests in MD StartThe Sorin Group, a medical device company, has made a minority investment in MD Start, of Switzerland. MD Start, a VC and medical technology incubator in Europe, is backed by Sofinnova Partners, Versant Ventures, Medtronic and Contract Medical International.
- MD Start Adds Investment from Versant Ventures, Sorin
MD Start, a European venture investor and incubator focused on medical device technology, has added backing from venture capital firm Versant Ventures, and European medical device company, Sorin Group. Terms of the investment were not released. Based in Lausanne, Switzerland, MD Start aims to provide capital for European inventors focused on medical devices.
IPO Momentum Turns Into New Year WhimperOverall, the IPO market rebounded well in 2010
- Synosia Therapeutics Raises $30 Million In Series C Round
Synosia Therapeutics raised $30M in a Series C financing round. UCB was a new investors in the Switzerland-based biotherapeutics company that is focused on neurology and psychiatry. It invested $20 million. Existing investors Versant Ventures, 5Am Ventures, Novo A/S, Aravis Venture, Investor Growth Capital and Swiss Helvetia Fund invested the other $10 million. UCB’s President of North American Operations Greg Duncan and Executive Vice President of Drug Discovery and President of UCB New Medicines Ismail Kola will serve as Synosia directors.
- IPO Profiles, August
Detailed profiles of the seven VC-backed companies that went public in August: Ambow Education, Kanghui Medical Innovation, Make My Trip, MediaMind Technologies, NuPathe, RealPage and Trius Therapeutics
- OpGen Completes $17m Series B Financing
OpGen, Inc., a Maryland-based commercial phase genomics company, completed a $17 million Series B round of equity financing. The new round of financing was led by jVen Capital with participation from the company’s other major investors, including CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Versant Ventures. Evan Jones of jVen Capital has been named as executive chairman of OpGen’s boards.
- Sci-fi, bionics not for TV anymore
Many VCs remain wary, but others believe they can’t go wrong betting on bionic technologies